Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H10I4O4 |
| Molecular Weight | 821.9089 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(I)C=C(C=C1I)C2(OC(=O)C3=CC=CC=C23)C4=CC(I)=C(O)C(I)=C4
InChI
InChIKey=FWQKRBDABCRWKV-UHFFFAOYSA-N
InChI=1S/C20H10I4O4/c21-13-5-9(6-14(22)17(13)25)20(10-7-15(23)18(26)16(24)8-10)12-4-2-1-3-11(12)19(27)28-20/h1-8,25-26H
| Molecular Formula | C20H10I4O4 |
| Molecular Weight | 821.9089 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18143449
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18143449
Iodophthalein was used as an iodine-containing X-ray contrast agent in icteric subjects. There is also existed mention, that iodophthalein has also been used as a wound treatment, and for the treatment of intestinal catarrhs. But nowadays more modern drugs are being used.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2026 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11931626 |
3.0 µM [IC50] | ||
Target ID: CHEMBL2386 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11931626 |
11.0 µM [IC50] | ||
Target ID: CHEMBL2575 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11931626 |
20.0 µM [IC50] | ||
Target ID: CHEMBL2522 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11931626 |
200.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Radiopaque contrast media XXXI-Glucoside conjugation of iodophthalein in rabbit. | 1977-01 |
|
| The elimination of iodophthalein in normal and icteric subjects. | 1949-07-18 |
|
| The excretion of iodophthalein in the human organism, with a method for determination of iodophthalein in tissue fluids. | 1948 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:31:38 GMT 2025
by
admin
on
Mon Mar 31 19:31:38 GMT 2025
|
| Record UNII |
R2CC46UA50
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID7048291
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | |||
|
m6351
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | Merck Index | ||
|
164900
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | |||
|
67846
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | |||
|
206-857-9
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | |||
|
R2CC46UA50
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | |||
|
4904
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY | |||
|
386-17-4
Created by
admin on Mon Mar 31 19:31:38 GMT 2025 , Edited by admin on Mon Mar 31 19:31:38 GMT 2025
|
PRIMARY |